Book description
The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public.- Presents a comprehensive view of the funding issues of R&D in this market sector, adopting a theory-to-practice approach
- A comprehensive and analytical review of the biopharmaceutical R&D literature and practice
- An overview of the various and competing/complementary theories of the firm and valuation methods as they apply to biopharmaceutical R&D
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of figures and tables
- Glossary
- Preface
- About the author
-
Chapter 1: Introduction to the biopharmaceutical market
- Abstract:
- 1.1 Introduction
- 1.2 Synopsis of the development of the biopharmaceutical market sector
- 1.3 Global growth of research and biopharmaceuticals
- 1.4 Biopharmaceutical and healthcare value chain
- 1.5 Demand for biopharmaceuticals
- 1.6 Approval process
- 1.7 Generic medicines
- 1.8 Pricing of drugs
- 1.9 Summary
- 1.10 References
- Chapter 2: Synopsis of theories of the firm and valuation methods
- Chapter 3: Innovation and the merging of the pharmaceutical and biotechnology industries
-
Chapter 4: The funding of basic research and public–private partnerships
- Abstract:
- 4.1 Introduction to research funding in the U.S.
- 4.2 Research funding in the European Union
- 4.3 Research funding in Asia
- 4.4 Technology transfer
- 4.5 Technology transfer offices
- 4.6 Bioclusters
- 4.7 Biocenters
- 4.8 Spill-overs and the diffusion of biopharmaceuticals
- 4.9 Summary
- 4.10 References
- Chapter 5: Strategic alliances
- Chapter 6: Angel and venture capital
-
Chapter 7: The initial public offering
- Abstract:
- 7.1 An introduction to the initial public offering
- 7.2 A brief synopsis of the history of stock exchanges
- 7.3 The IPO process in the United States
- 7.4 IPOs around the U.S.
- 7.5 Research and development expenditures and financial condition
- 7.6 IPO performance
- 7.7 Venture capital involvement
- 7.8 IPO as exit
- 7.9 IPO activity around the world
- 7.10 Summary
- 7.11 References
- Chapter 8: Conclusion
- Index
Product information
- Title: The Funding of Biopharmaceutical Research and Development
- Author(s):
- Release date: October 2013
- Publisher(s): Woodhead Publishing
- ISBN: 9781908818386
You might also like
book
Value Based Health Care: Linking Finance and Quality
Value-Based Health Care Linking Finance and Quality Yosef D. Dlugacz Value-Based Health Care? Value-Based Health Care?concisely …
book
Chemical Biology: Approaches to Drug Discovery and Development to Targeting Disease
An authoritative look at the application of chemical biology in drug discovery and development Based on …
book
Biopharmaceutical Supply Chains
The global pharmaceutical industry has been subjected to many challenges in the last decade, including more …
book
Why Smart Companies Are Giving Customers More Data
Companies looking for ways to stand out from their competition can offer customers data products that …